Patatin‐like phospholipase domain‐containing protein 3 and Liver Disease: Opportunities to Unravel Mechanisms Underlying Statistical Associations
Jérôme Boursier, Anna Mae Diehl – 18 September 2014
First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy
Gary James, Prabhjot Sidhu, Mohammad Raza – 18 September 2014
Prognosis of untreated hepatocellular carcinoma
Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Anna Pecorelli, Gian Lodovico Rapaccini, Mariella Di Marco, Luisa Benvegnù, Eugenio Caturelli, Marco Zoli, Franco Borzio, Maria Chiaramonte, Franco Trevisani, for the Italian Liver Cancer (ITA.LI.CA) group – 18 September 2014
Leukocyte‐Specific Protein 1: ANovel Regulator of Hepatocellular Proliferation and Migration Deleted in Human Hepatocellular Carcinoma
Kelly Koral, Shirish Paranjpe, William C. Bowen, Wendy Mars, Jianhua Luo, George K. Michalopoulos – 18 September 2014
First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy
Gary James, Prabhjot Sidhu, Mohammad Raza – 18 September 2014
A bridge too far: We have overstepped the line for extended deceased donors
Antonio D. Pinna, Flavia Neri, Matteo Ravaioli – 13 September 2014
Living donor liver transplantation: Alive and well
Michael D. Leise – 13 September 2014
Opportunities for scientific expansion of the deceased donor pool in liver transplantation
Alix P.M. Matton, Robert J. Porte – 13 September 2014
Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension
Sun Young Ahn, Soo Young Park, Won Young Tak, Yu Rim Lee, Eun Jeong Kang, Jung Gil Park, Won Kee Lee, Kwan Lee, Young Oh Kweon – 13 September 2014 – New definitions and criteria were released at the Baveno V consensus meeting. The purposes of this study were to verify Baveno V definitions and criteria for failure to control bleeding and to determine the usefulness of the combined use of the Adjusted Blood Requirement Index [ABRI: (number of blood units)/(final hematocrit‐initial hematocrit)+0.01] with Baveno V criteria.
A bridge too far: We have not overstepped the line for extended deceased donors
Constantino Fondevila – 13 September 2014